Immunology

How antibody therapy affects the breadth of COVID mRNA vaccines

Nearly three years into the pandemic, many of us now carry antibodies against the virus—due to an infection or two, a few doses of mRNA vaccine, or a round of monoclonal-antibody treatment. But not all immune responses ...

Vaccination

EU backs new Omicron vaccines for first jabs

The EU's drug watchdog on Tuesday said two COVID vaccines targeting new types of the Omicron variant could now be used for people's first vaccinations, and not just for boosters.

HIV & AIDS

Scientists may be closer to effective HIV vaccine

It's thought that for an HIV vaccine to be widely effective, it will have to spur the body to make special antibodies that can neutralize a broad range of HIV strains. Now scientists say they have taken an essential step ...

Diseases, Conditions, Syndromes

A possible vaccine against the bacteria that cause UTIs

A team of researchers at Duke University has developed a vaccine against uropathogenic E. coli (UPEC), the type of bacteria that cause urinary tract infections (UTIs) in humans. In their paper published in the journal Science ...

page 15 from 40